Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 26 May 2026 for Bausch Health Companies Inc.. Read the official filing
Filing timeline
BuySaleEiry Roberts
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eiry Roberts: trading record in brief
This profile gathers the share dealings of Eiry Roberts across 3 companies, led by Neurocrine Biosciences Inc, Amicus Therapeutics, Inc. and Bausch Health Companies Inc. We count 24 filings; the first trade dates from 10 June 2021 and the latest from 22 May 2026.
Every open-market trade on record is a sale: 10 sales worth €3.8M. Outside the open market, there are 6 share grants and 7 option exercises.
On 26 May 2026 came the latest disclosure, a share grant in Bausch Health Companies Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eiry Roberts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
45,871 shares0Common Shares, No Par ValueSEC:0000885590-26-000082:0
76,275 shares@ US$14.500.024% mcap100.0% of flowCommon StockSEC:0001193125-26-182275:0
20,414 shares0Common StockSEC:0000950170-25-083215:0
2,113 shares0Common StockSEC:0000914475-25-000069:0
1,860 shares0Common StockSEC:0000914475-25-000051:0
2,769 shares0Common StockSEC:0000914475-25-000029:0
5,140 shares@ US$77.814.4% of flowCommon StockSEC:0000914475-24-000220:0
11,847 shares0Common StockSEC:0000950170-24-071007:0
1,114 shares@ US$132.96391.6% of flowCommon StockSEC:0000914475-24-000076:0
1,121 shares@ US$142.23561.8% of flowCommon StockSEC:0000914475-24-000049:0
1,457 shares@ US$140.79062.2% of flowCommon StockSEC:0000914475-24-000031:0
10,000 shares@ US$126.744813.7% of flowCommon StockSEC:0001209191-23-059774:0
6,978 shares@ US$81.056.2% of flowCommon StockSEC:0001209191-23-058683:0
38,722 shares@ US$77.8133.2% of flowCommon StockSEC:0001209191-23-058116:0
8,396 shares@ US$77.817.2% of flowCommon StockSEC:0001209191-23-057986:0
3,198 shares@ US$107.37583.7% of flowCommon StockSEC:0001209191-23-047140:0
8,584 shares0Common StockSEC:0001209191-23-036422:0
14,400 shares@ US$103.476316.0% of flowCommon StockSEC:0001209191-23-025763:0
1,121 shares@ US$105.80041.3% of flowCommon StockSEC:0001209191-23-007916:0
1,457 shares@ US$109.98871.8% of flowCommon StockSEC:0001209191-23-006282:0
12,671 shares0Common StockSEC:0001209191-22-035847:0
1,623 shares@ US$80.76761.4% of flowCommon StockSEC:0001209191-22-008216:0
2,632 shares@ US$74.50142.1% of flowCommon StockSEC:0001209191-22-003104:0
22,759 shares0Common StockSEC:0001209191-21-040374:0
24 of 24 declarations
